| [1] |
刘兴会. 产后出血预防与处理指南(2014)[J]. 中华妇产科杂志，2014，49(9)：641-646.
|
| [2] |
American College of Obstetricians and Gynecologists. Practice Bulletin No. 183: Postpartum Hemorrhage[J]. Obstet Gynecol, 2017，130(4)：e168-e186.
|
| [3] |
Woman Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial [J]. Lancet, 2017，389(10084)：2105-2116.
|
| [4] |
Cannon JW. Hemorrhagic Shock[J]. N Engl J Med, 2018，378(4)：370-379.
|
| [5] |
Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016[J]. Eur J Anaesthesiol, 2017，34(6)：332-395.
|
| [6] |
De Robertis E, Kozek-Langenecker SA, Tufano R, et al. Coagulopathy induced by acidosis, hypothermia and hypocalcaemia in severe bleeding [J]. Minerva Anestesiol, 2015，81(1)：65-75.
|
| [7] |
Muñoz M, Stensballe J, Ducloy-Bouthors AS, et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement[J]. Blood Transfus, 2019，17(2)：112-136.
|
| [8] |
Mavrides E, Allard S, Chandraharan E, et al. Prevention and Management of Postpartum Haemorrhage: Green-top Guideline No.52[J]. BJOG, 2017，124(5)：e106-e149.
|
| [9] |
Queensland Clinical Guidelines. Postpartum haemorrhage Guideline No.MN18.1-V10-R23 Primary postpartum haemorrhage. Queensland Health. 2021.
URL
|
| [10] |
World Health Organization. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage, Geneva: WHO，2012.ISBN-13: 978-92-4-154850-2.
|
| [11] |
刘兴会，陈锰. 基于大数据的产后出血临床处理[J]. 中国实用妇科与产科杂志，2018，34(1): 33-37.
|
| [12] |
Elagamy A, Abdelaziz A, Ellaithy M. The use of cell salvage in women undergoing cesarean hysterectomy for abnormal placentation [J]. Int J Obstet Anesth, 2013，22(4)：289-293.
|
| [13] |
Milne ME, Yazer MH, Waters JH. Red blood cell salvage during obstetric hemorrhage[J]. Obstet Gynecol, 2015，125(4)：919-923.
|
| [14] |
Ho KM, Leonard AD. Concentration-dependent effect of hypocalcaemia on mortality of patients with critical bleeding requiring massive transfusion: a cohort study[J]. Anaesth Intensive Care, 2011，39(1)：46-54.
|
| [15] |
Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage[J]. Anaesthesia, 2015，70(Suppl 1)：78-86.
|
| [16] |
Levi M. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism)[J]. Thromb Res, 2013，131(Suppl 1)：S32-S34.
|
| [17] |
Shields LE, Smalarz K, Reffigee L, et al. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products[J]. Am J Obstet Gynecol, 2011，205(4)：368.e1-8.
|
| [18] |
Treml AB, Gorlin JB, Dutton RP, et al. Massive Transfusion Protocols: A Survey of Academic Medical Centers in the United States [J]. Anesth Analg, 2017，124(1)：277-281.
|
| [19] |
O′brien KL, Shainker SA, Lockhart EL. Transfusion Management of Obstetric Hemorrhage[J]. Transfus Med Rev，2018，32(4)：249-255.
|